{"id":"https://openalex.org/W4362584591","doi":"https://doi.org/10.3389/fphar.2023.1143928","title":"Factors influencing bioequivalence evaluation of insulin biosimilars based on a structural equation model","display_name":"Factors influencing bioequivalence evaluation of insulin biosimilars based on a structural equation model","alternate_titles":[],"publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362584591","doi":"https://doi.org/10.3389/fphar.2023.1143928","pmid":"https://pubmed.ncbi.nlm.nih.gov/37077814","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10106704"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2023.1143928","doi":"https://doi.org/10.3389/fphar.2023.1143928","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3389/fphar.2023.1143928","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1143928/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4362584591"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1143928/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032848942","display_name":"Huarui Shao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87780372","display_name":"Chongqing Medical University","ror":"https://ror.org/017z00e58","country_code":"CN","type":"education","lineage":["https://openalex.org/I87780372"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huarui Shao","raw_affiliation_strings":["College of Pharmacy, Chongqing Medical University, Chongqing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy, Chongqing Medical University, Chongqing, China","institution_ids":["https://openalex.org/I87780372"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103204214","display_name":"Yi Tao","orcid":"https://orcid.org/0009-0001-1144-8682","observed_orcids":["https://orcid.org/0009-0001-1144-8682"]},"institutions":[{"id":"https://openalex.org/I4210129459","display_name":"The Affiliated Yongchuan Hospital of Chongqing Medical University","ror":"https://ror.org/033vnzz93","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129459"]},{"id":"https://openalex.org/I87780372","display_name":"Chongqing Medical University","ror":"https://ror.org/017z00e58","country_code":"CN","type":"education","lineage":["https://openalex.org/I87780372"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yi Tao","raw_affiliation_strings":["2 Phase I Clinical Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China","Phase I Clinical Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 Phase I Clinical Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China","institution_ids":["https://openalex.org/I87780372"]},{"raw_affiliation_string":"Phase I Clinical Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China","institution_ids":["https://openalex.org/I4210129459"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017802954","display_name":"Chengyong Tang","orcid":"https://orcid.org/0000-0003-3293-9533","observed_orcids":["https://orcid.org/0000-0003-3293-9533"]},"institutions":[{"id":"https://openalex.org/I87780372","display_name":"Chongqing Medical University","ror":"https://ror.org/017z00e58","country_code":"CN","type":"education","lineage":["https://openalex.org/I87780372"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Chengyong Tang","raw_affiliation_strings":["Phase I Clinical Research Center, Bishan Hospital of Chongqing Medical University, Chongqing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Research Center, Bishan Hospital of Chongqing Medical University, Chongqing, China","institution_ids":["https://openalex.org/I87780372"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017802954","https://openalex.org/A5103204214"],"corresponding_institution_ids":["https://openalex.org/I4210129459","https://openalex.org/I87780372"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":0.0984,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.30469415,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"14","issue":null,"first_page":"1143928","last_page":"1143928"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilar-insulin","display_name":"biosimilar insulin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7929999828338623},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.996999979019165},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7070000171661377},{"id":"https://openalex.org/keywords/structural-equation-modeling","display_name":"structural equation modeling","score":0.6930000185966492},{"id":"https://openalex.org/keywords/influencing-factors","display_name":"influencing factors","score":0.5870000123977661},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.9423250555992126},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5880376100540161},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5876792073249817},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5136739611625671},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4686626195907593},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4554637372493744},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.45001333951950073},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4496151804924011},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3836904764175415},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.1005738377571106},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2023.1143928","doi":"https://doi.org/10.3389/fphar.2023.1143928","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3389/fphar.2023.1143928","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1143928/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10106704","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10106704","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10106704/pdf/fphar-14-1143928.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:37077814","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37077814","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:0dc6d449527644118df335ba98878651","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/0dc6d449527644118df335ba98878651","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 14 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2023.1143928","doi":"https://doi.org/10.3389/fphar.2023.1143928","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3389/fphar.2023.1143928","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1143928/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362584591.pdf","grobid_xml":"https://content.openalex.org/works/W4362584591.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1467621320","https://openalex.org/W1498305210","https://openalex.org/W1906243187","https://openalex.org/W1979325667","https://openalex.org/W2026283367","https://openalex.org/W2027141319","https://openalex.org/W2029811918","https://openalex.org/W2030136986","https://openalex.org/W2036486575","https://openalex.org/W2041489038","https://openalex.org/W2133581031","https://openalex.org/W2149485684","https://openalex.org/W2160850704","https://openalex.org/W2435902233","https://openalex.org/W2738844148","https://openalex.org/W2792117826","https://openalex.org/W2810846480","https://openalex.org/W2887096447","https://openalex.org/W2915931344","https://openalex.org/W2950336427","https://openalex.org/W2954858608","https://openalex.org/W2973237786","https://openalex.org/W2973908960","https://openalex.org/W2980191403","https://openalex.org/W3047235369","https://openalex.org/W3092394647","https://openalex.org/W3123637307","https://openalex.org/W3208688645","https://openalex.org/W3215319113","https://openalex.org/W4224260950","https://openalex.org/W4254445254","https://openalex.org/W4285210367","https://openalex.org/W4286539982"],"related_works":["https://openalex.org/W4386944727","https://openalex.org/W2109713336","https://openalex.org/W4205880857","https://openalex.org/W4408829889","https://openalex.org/W2094097146","https://openalex.org/W4318339392","https://openalex.org/W3030840877","https://openalex.org/W2604709956","https://openalex.org/W35589611","https://openalex.org/W4381378245"],"abstract_inverted_index":{"Objective:":[0],"This":[1],"study":[2],"aimed":[3],"to":[4,19,76,95,120,147,165,242,254,298],"explore":[5,243],"the":[6,9,25,29,78,82,122,148,155,166,185,189,215,221,244,248,255,258,278,300,309],"factors":[7,124,246,307],"affecting":[8,308],"bioequivalence":[10,126,162,216,249,286],"of":[11,28,33,81,125,134,217,250,257,277,282,288,302],"test":[12,75],"and":[13,31,65,101,110,154,181,201,220,267,280,295,304],"reference":[14],"insulin":[15,34,86,283,289],"preparations":[16],"so":[17],"as":[18],"provide":[20],"a":[21,71],"scientific":[22],"basis":[23],"for":[24,106,247,274],"consistency":[26,275,301],"evaluation":[27,276],"quality":[30,279],"efficacy":[32,281],"biosimilars.":[35,284],"Methods:":[36],"A":[37,132,236],"randomized,":[38],"open,":[39],"two-sequence,":[40],"single-dose,":[41],"crossover":[42],"design":[43],"was":[44,88,118,240],"used":[45,241],"in":[46,58,174],"this":[47],"study.":[48],"Subjects":[49,144],"were":[50,68,104,142,145],"randomly":[51],"divided":[52],"into":[53],"TR":[54],"or":[55],"RT":[56],"groups":[57],"equal":[59],"proportion.":[60],"The":[61,84,113],"glucose":[62,67,73],"infusion":[63],"rate":[64],"blood":[66],"measured":[69],"by":[70,90,127,161],"24-h":[72],"clamp":[74],"evaluate":[77,96],"pharmacodynamic":[79],"parameters":[80],"preparation.":[83],"plasma":[85],"concentration":[87],"determined":[89],"liquid":[91],"chromatography\u2013mass":[92],"spectrometry":[93],"(LC-MS/MS)":[94],"pharmacokinetic":[97],"parameters.":[98],"WinNonlin":[99],"8.1":[100],"SPSS":[102],"23.0":[103],"applied":[105],"PK/PD":[107],"parameter":[108],"calculation":[109],"statistical":[111,172,238],"analysis.":[112],"structural":[114,190,259],"equation":[115,191,260],"model":[116,239],"(SEM)":[117],"constructed":[119],"analyze":[121],"influencing":[123,245],"using":[128],"Amos":[129],"24.0.":[130],"Results:":[131],"total":[133],"177":[135],"healthy":[136],"male":[137],"subjects":[138,303],"aged":[139],"18\u201345":[140],"years":[141],"analyzed.":[143],"assigned":[146],"equivalent":[149],"group":[150,157],"(N":[151,158],"=":[152,159,196,206,209,230,233],"55)":[153],"non-equivalent":[156],"122)":[160],"results,":[163],"according":[164],"EMA":[167],"guideline.":[168],"Univariate":[169],"analysis":[170],"showed":[171],"differences":[173],"albumin,":[175],"creatinine,":[176],"Tmax,":[177],"bioactive":[178,202,222,268],"substance":[179,203,223,269],"content,":[180],"adverse":[182,193,227,265],"events":[183,194,228,266],"between":[184],"two":[186,218,251],"groups.":[187],"In":[188],"model,":[192,261],"(\u03b2":[195,205,229],"0.342;":[197],"p":[198,208,232],"<":[199],"0.001)":[200],"content":[204,224,270],"\u22120.189;":[207],"0.007)":[210],"had":[211],"significant":[212],"impacts":[213],"on":[214],"preparations,":[219],"significantly":[225],"affected":[226],"0.200;":[231],"0.007).":[234],"Conclusion:":[235],"multivariate":[237],"preparations.":[252],"According":[253],"result":[256],"we":[262],"proposed":[263],"that":[264],"should":[271,291],"be":[272],"optimized":[273],"Furthermore,":[285],"trials":[287],"biosimilars":[290],"strictly":[292],"obey":[293],"inclusion":[294],"exclusion":[296],"criteria":[297],"ensure":[299],"avoid":[305],"confounding":[306],"equivalence":[310],"evaluation.":[311]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4362584591","counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-04-06T00:00:00"}
